269 

 Table 5-3 Continued 



Explanation of remarks (continued): 



C) Compound was previously reported in the literature as a 

 compound having dermal origin (table 5-1). 



D) Reported as being observed in the cryo-focused GC/MS 

 analyses (table 5-2). 



E) See text for further explanation. 



